The David H. Koch Institute for Integrative Cancer Research at MITThe David H. Koch Institute for Integrative Cancer Research at MIT

Massachusetts Institute of Technology

National Cancer Institute Cancer Center

Science + Engineering... Conquering Cancer Together

Bridge Project Awards Ceremony and Luncheon: March 2013

The event, which took place on March 21, 2013, was hosted by MIT President L. Rafael Reif, and featured opening remarks by Reif, David M. Livingston, Deputy Director of the DF/HCC, Tyler Jacks, Director of the Koch Institute, and David Nathan, President Emeritus, Dana-Farber Cancer Institute. The award ceremony and luncheon included presentations by researchers working on the four newly awarded Bridge Project projects:

"Osmotic Micro-Pump as Delivery System for Intraperitoneal Chemotherapy in the Treatment of Advanced Ovarian Cancer," a collaboration between Michael Cima of the Koch Institute, Michael Birrer of Massachusetts General Hospital, and Marcela Del Carmen of Massachusetts General Hospital

"Developing Novel Therapeutic Approaches in Small Cell Lung Carcinoma Using Genetically Engineered Mouse Models and Human Circulating Tumor Cells," a collaboration between Tyler Jacks of the Koch Institute, Jeffrey Engelman of Massachusetts General Hospital, and Daniel Haber of Massachusetts General Hospital. (Presented by Anna F. Farago of David H. Koch Institute for Integrative Cancer Research at MIT and Dana-Farber/Partners Cancer Care.)

"Detection of 'Invisible' Nevi in Redheads," a collaboration between David Fisher of Massachusetts General Hospital, Peter So of the MIT Departments of Mechanical Engineering and Biological Engineering, and Conor Evans of Massachusetts General Hospital

"Targeting Mutant IDH1 in Malignant Gliomas," a collaboration between Matthew Vander Heiden of the Koch Institute, William G. Kaelin, Jr. of the Dana-Farber Cancer Institute, and Daniel Cahill of Massachusetts General Hospital

The event also featured a presentation from one of the existing Bridge Project teams:

"A Pancreatobiliary Chemotherapy Eluting Stent for Pancreatic Ductal Adenocarcinomas," a collaboration between Jeffrey W. Clark of Massachusetts General Hospital, Robert S. Langer of the Koch Institute, and Elazer Edelman of the Institute of Medical Engineering and Sciences at MIT and the Koch Institute